Related Experiment Video

Updated: Oct 4, 2026

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

No evidence of somatic FGFR3 mutation in various types of carcinoma

M Karoui1, H Hofmann-Radvanyi, U Zimmermann

  • 1Fédération des Spécialités Digestives, Hôpital Ambroise Paré, Université Paris V, 92104 Boulogne Cedex, France.

Oncogene
|August 30, 2001
PubMed

Insights

Fibroblast growth factor receptor 3 (FGFR3) gene mutations are linked to skeletal disorders and some cancers. This study found no FGFR3 mutations in various common tumors, suggesting they are specific to bladder cancer.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Germline mutations in the fibroblast growth factor receptor 3 (FGFR3) gene are known to cause skeletal dysplasias and craniosynostosis syndromes.
  • Activating FGFR3 mutations, similar to those in skeletal disorders, have been identified in various cancers, notably bladder carcinoma.
  • The prevalence and specificity of FGFR3 mutations across different cancer types require further investigation.

Purpose of the Study:

  • To investigate the prevalence of FGFR3 gene mutations in a diverse range of primary human tumors.
  • To determine if FGFR3 mutations, previously associated with skeletal conditions and bladder cancer, occur in other common cancer types.

Main Methods:

  • Analysis of 116 primary tumors from the upper aerodigestive tract, esophagus, stomach, lung, and skin.
  • Utilized Single-Strand Conformation Polymorphism (SSCP) and DNA sequencing to detect mutations.
  • Focused analysis on regions known to harbor previously described FGFR3 point mutations in skeletal dysplasias and cancers.

Main Results:

  • No FGFR3 mutations were detected in any of the analyzed tumor types (upper aerodigestive tract, esophagus, stomach, lung, skin).
  • This finding contrasts with the known high frequency of FGFR3 mutations in bladder carcinoma.
  • The results indicate that FGFR3 mutations are not a common feature in the investigated tumor spectrum.

Conclusions:

  • The study suggests that FGFR3 mutations are restricted to a limited set of tumor types.
  • Current evidence strongly points towards FGFR3 mutations being highly specific to bladder carcinomas.
  • Further research may elucidate the precise oncogenic role and specificity of FGFR3 mutations in human cancers.

More Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...